Your weekly roundup of the latest news from Drug Topics®.
Childhood vaccinations took a downturn during the pandemic. Now is the time to get them done and pharmacists can help.
Moderna has announced positive topline results from a phase 3 pivotal efficacy study of mRNA-1345, the company’s investigational mRNA vaccine targeting respiratory syncytial virus (RSV) in older adults.
The updates include new recommendations for COVID-19 and pneumococcal vaccines.
Previously hepatitis B vaccines have offered lower levels of protection for people living with HIV. New research indicates that a 3-dose series could offer much better protection.
New approvals include gene therapies, first-in-class drugs, treatments for rare diseases, and cancer, as well as biosimilars.
Podcast: Discussing the Shared Central Fulfillment Solution with iA
May 6th 2024Brian Nowosielski, associate editor with Drug Topics, sat down with Tom Utech and Reed Richardson of iA, an innovative pharmacy fulfillment company. Utech, CEO of iA, and Richardson, Chief Commercial Officer of iA, discussed the company's new shared central fulfillment solution. The new solution, designed to streamline processes within the pharmacy, is a technological innovation with life-saving benefits for patients.